These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 25204587)
1. VEGF levels in CSF and serum in mild ALS patients. Gao L; Zhou S; Cai H; Gong Z; Zang D J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients. Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676 [TBL] [Abstract][Full Text] [Related]
6. CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682 [TBL] [Abstract][Full Text] [Related]
7. Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Devos D; Moreau C; Lassalle P; Perez T; De Seze J; Brunaud-Danel V; Destée A; Tonnel AB; Just N Neurology; 2004 Jun; 62(11):2127-9. PubMed ID: 15184633 [TBL] [Abstract][Full Text] [Related]
8. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia. Just N; Moreau C; Lassalle P; Gosset P; Perez T; Brunaud-Danel V; Wallaert B; Destée A; Defebvre L; Tonnel AB; Devos D Neuromuscul Disord; 2007 Feb; 17(2):169-73. PubMed ID: 17142042 [TBL] [Abstract][Full Text] [Related]
9. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis. Liu J; Gao L; Zang D PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and amyotrophic lateral sclerosis: the interplay with exercise and noninvasive ventilation. Carilho R; de Carvalho M; Swash M; Pinto S; Pinto A; Costa J Muscle Nerve; 2014 Apr; 49(4):545-50. PubMed ID: 23868282 [TBL] [Abstract][Full Text] [Related]
11. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis. Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Zheng Y; Gao L; Wang D; Zang D Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118 [TBL] [Abstract][Full Text] [Related]
13. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408 [TBL] [Abstract][Full Text] [Related]
14. Clinical factors and vascular endothelial growth factor as determinants of disease progression in Indian patients with amyotrophic lateral sclerosis. Thomas A; Garg D; Srivastava AK; Kumar A; Pandit AK; Vibha D; Vivekanandhan S; Shukla G; Prasad K Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):46-52. PubMed ID: 37710422 [TBL] [Abstract][Full Text] [Related]
16. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831 [TBL] [Abstract][Full Text] [Related]
17. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model. Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144 [TBL] [Abstract][Full Text] [Related]
18. Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line. Vijayalakshmi K; Ostwal P; Sumitha R; Shruthi S; Varghese AM; Mishra P; Manohari SG; Sagar BC; Sathyaprabha TN; Nalini A; Raju TR; Alladi PA Mol Neurobiol; 2015; 51(3):995-1007. PubMed ID: 24880751 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis. Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331 [TBL] [Abstract][Full Text] [Related]
20. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Kuhle J; Lindberg RL; Regeniter A; Mehling M; Steck AJ; Kappos L; Czaplinski A Eur J Neurol; 2009 Jun; 16(6):771-4. PubMed ID: 19236470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]